Appropriate empirical antimicrobial therapy was associated with a lower risk of 30-days attributable mortality in patients with carbapenem resistance (OR = 0.23, 95% confidence interval 0.07–0.77, p = 0.02), whereas such association lacked in patients without carbapenem resistance, though such difference did not reach statistical significance.
← all excerpts
Association of capsular types with carbapenem resistance, disease severity, and mortality in <i>Acinetobacter baumannii</i>.
1
—
—